Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Stable RAGE-Heparan Sulfate Complexes Are Essential for Signal Transduction
2013
ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome
2006
Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction
2010
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE)
2011
The DNA-damage response in human biology and disease
2009 StandoutNature
Severity of diabetic microvascular complications is associated with a low soluble RAGE level
2008
The RAGE Axis
2010
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
AGEs and Diabetic Retinopathy
2010
Ischemia and reperfusion—from mechanism to translation
2011 Standout
S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor Trafficking
2008 StandoutNobel
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
2009
Insulin Resistance, Hyperglycemia, and Atherosclerosis
2011
Chronic Thromboembolic Pulmonary Hypertension
2013
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease
2009
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
The biology of RAGE and its ligands: Uncovering mechanisms at the heart of diabetes and its complications
2007
Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes
2006
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study
2009
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Guillain-Barré syndrome
2016 Standout
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding
2011
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
2008
Immunogenic cell death in cancer and infectious disease
2016 Standout
Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function
2013
Nonresolving Inflammation
2010 Standout
Direct antiatherosclerotic effects of PPAR agonists
2008
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
The role of transcription-independent damage signals in the initiation of epithelial wound healing
2013
EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages
2011
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Imaging Atherosclerosis and Vulnerable Plaque
2010
Antithrombotic Therapy for VTE Disease
2012 Standout
Binding of S100 proteins to RAGE: An update
2008
Pathologies Involving the S100 Proteins and Rage
2007
Psoriasis
2015 Standout
The Early-Immediate Gene EGR-1 Is Induced by Transforming Growth Factor-β and Mediates Stimulation of Collagen Gene Expression
2006
PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis
2022
Structural Basis of Protein Kinase C Isoform Function
2008
RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3β Signaling Pathways
2010
C-Reactive Protein
2009
Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse
2010
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
2005
Asymmetric Dimethylarginine Is Increased in Chronic Thromboembolic Pulmonary Hypertension
2007
DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells
2012
Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis
2007
Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling
2016
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers
2015
Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes – focus on pancreatitis and pancreas cancer
2014
Origin and physiological roles of inflammation
2008 StandoutNature
Sterile inflammation: sensing and reacting to damage
2010 Standout
Structural Basis for Ligand Recognition and Activation of RAGE
2010
Mechanisms of distal axonal degeneration in peripheral neuropathies
2015
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
2011
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-κB pathways
2009
Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective
2012
Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
2016
The receptor RAGE: Bridging inflammation and cancer
2009
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
2008
RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
2009
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Inhibitors of Advanced Glycation and Endoplasmic Reticulum Stress
2011
Structural Insights into Calcium-Bound S100P and the V Domain of the RAGE Complex
2014
Cardiac Remodeling in Obesity
2008
Chronic thromboembolic pulmonary hypertension
2014
Neutrophil recruitment and function in health and inflammation
2013 Standout
HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
2011
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Redox Regulation of Protein Kinases as a Modulator of Vascular Function
2010
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
2008
Pulmonary Vascular Reactivity and Prognosis in Patients With Chronic Thromboembolic Pulmonary Hypertension
2009
Increased Atherosclerotic Lesion Calcification in a Novel Mouse Model Combining Insulin Resistance, Hyperglycemia, and Hypercholesterolemia
2007
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Alternative splicing of the murine receptor for advanced glycation end‐products (RAGE) gene
2009
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
2009
Oxidative Stress and Diabetic Complications
2010 Standout
Immune and Inflammatory Mechanisms of Atherosclerosis
2009
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
RAGE: a novel biological and genetic marker for vascular disease
2009
Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice
2007
Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes
2010
Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products
2013
HMGB1 and RAGE in Inflammation and Cancer
2010
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts
2009
Is RAGE Still A Therapeutic Target For Alzheimer’s Disease?
2012
Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes
2011
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
2010
Mechanisms of Diabetic Complications
2013 Standout
Reduction of Diabetes-Induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cβ–Null Mice
2006
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Diagnostic Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Practice Guideline
2010
Vascular Calcification
2008 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
The Impact of Macrophage Insulin Resistance on Advanced Atherosclerotic Plaque Progression
2010
Works of Evis Harja being referenced
Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
2010
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
2008
Protein Kinase C β/Early Growth Response-1 Pathway
2006
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
2008
The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study
2005
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
2005
Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension
2007
Noninvasive monitoring the biology of atherosclerotic plaque development with radiolabeled annexin V and matrix metalloproteinase inhibitor in spontaneous atherosclerotic mice
2010
An Analysis of Characteristics of Subjects Examined for Incretin Effects on Pancreatic Pathology
2013
Early Growth Response-1 Promotes Atherogenesis
2003
Receptor for Advanced-Glycation End Products
2006
Identification, classification, and expression of RAGE gene splice variants
2007
Mice deficient in PKC β and apolipoprotein E display decreased atherosclerosis
2008
Central Role of PKCβ in Neointimal Expansion Triggered by Acute Arterial Injury
2005